Skip to main content

Table 5 Hazard ratio and 95% confidence intervals of transplantation comparing HDF versus. HD stratified by study

From: The probability of receiving a kidney transplantation in end-stage kidney disease patients who are treated with haemodiafiltration or haemodialysis: a pooled individual participant data from four randomised controlled trials

  

CONTRAST

Hazard ratio (95%-CI)

p-value for interaction

ESHOL

Hazard ratio (95%-CI)

p-value for interaction

Overall

 

1.06 (0.77–1.45)

–

1.19 (0.88–1.61)

–

Sex

Male

1.00 (0.66–1.52)

 

1.09 (0.75–1.58)

 

Female

1.14 (0.69–1.86)

0.70

1.43 (0.85–2.40)

0.40

Age

< 60 years

1.47 (0.98–2.19)

 

1.27 (0.85–1.88)

 

≥ 60 years

0.65 (0.38–1.11)

0.02

1.08 (0.68–1.72)

0.61

Diabetes

No

1.02 (0.71–1.46)

 

1.16 (0.83–1.61)

 

Yes

1.42 (0.68–2.99)

0.43

1.29 (0.60–2.78)

0.80

History of CVD

No

1.16 (0.81–1.67)

 

1.29 (0.92–1.80)

 

Yes

0.80 (0.40–1.59)

0.35

0.97 (0.48–1.94)

0.46

Albumin

<  4 g/dL

0.98 (0.57–1.69)

 

1.56 (0.81–3.02)

 

≥ 4 g/dL

1.07 (0.72–1.60)

0.80

1.12 (0.79–1.59)

0.38

Dialysis vintage

<  30 months

1.28 (0.83–1.98)

 

1.07 (0.74–1.55)

 

≥ 30 months

0.85 (0.52–1.38)

0.21

1.47 (0.87–2.47)

0.33

Fistula

No

1.65 (0.66–4.08)

 

1.58 (0.45–5.48)

 

Yes

1.00 (0.71–1.41)

0.32

1.19 (0.87–1.63)

0.67